Central Nervous System Drugs Market Global Report 2017

Central nervous system drugs market include medications that are used in the treatment of diseases affecting the brain or spinal cord. The major diseases in the market include bipolar disorders, anxiety, depression, Parkinson’s disease, Alzheimer’s disease, and epilepsy. Top selling neurological drugs in 2016 include Copaxone, Lyrica, and Tecfidera.

The global central nervous system drugs market was estimated to be around $68 billion as of 2016. The central nervous system drugs market made up around 6% of the overall pharmaceuticals market in 2016. The central nervous system drugs market was the eighth largest market in the global pharmaceutical market in 2016.

Regenerative Therapies For Central Nervous System Diseases
Regenerative therapies for the treatment of central nervous system diseases is one of the emerging trend in the global central nervous system drugs market. These therapies will help in the healing process by replacing or regenerating human cells, tissues, and organs. The major regenerative therapies include transplantation by embryonic stem cells, usage of matrix such as fibrin, collagen, and hyaluronic acid.

1. Central Nervous System Drugs Market Characteristics;

2. Central Nervous System Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Central Nervous System Drugs Market Customer Information;

5. Central Nervous System Drugs Market Segmentation;
5.1. Global Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 5.2. Global Central Nervous System Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Central Nervous System Drugs Market Trends And Strategies;

6. Central Nervous System Drugs Market Regional And Country Analysis;
6.1. Global Central Nervous System Drugs Market, 2016, By Region; 6.2. Global Central Nervous System Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Central Nervous System Drugs Market, 2016, By Country; 6.4. Central Nervous System Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6 Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7 Global Pharmaceutical Market Segments, 2016, By Country; 6.8 Global Pharmaceutical Drugs Market Segments, 2016, By Country;

7. Global Central Nervous System Drugs Market Comparison With Macro Economic Factors;
7.1. Central Nervous System Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Central Nervous System Drugs Expenditure, Global;

8. Central Nervous System Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Central Nervous System Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Central Nervous System Drugs Expenditure, By Country;

9. Central Nervous System Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Central Nervous System Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Central Nervous System Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Central Nervous System Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Central Nervous System Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Parkinsons Disease, 2014, By Country; 9.10. Global Number Of Psychiatrists, 2016, By Country; 9.11. Global Central Nervous System Drugs Market Revenue Versus Number Of Psychiatrists, 2016, By Country; 9.12. Global Number Of General Practitioners 2016, By Country; 9.13. Global Central Nervous System Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;

10. Asia-Pacific Central Nervous System Drugs Market;
10.1.1. Asia-Pacific Central Nervous System Drugs Market Overview; 10.1.2. Asia-Pacific Central Nervous System Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Central Nervous System Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 10.2. Asia-Pacific Central Nervous System Drugs Market: Country Analysis; 10.3. China Central Nervous System Drugs Market; 10.3.1. China Central Nervous System Drugs Market Overview; 10.3.2. China Central Nervous System Drugs Historic Market, 2012 - 2016; 10.3.3. China Central Nervous System Drugs Forecast Market, 2016 - 2020; 10.3.4. China Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 10.3.5. China Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020; 10.4. India Central Nervous System Drugs Market; 10.4.1. India Central Nervous System Drugs Market Overview; 10.4.2. India Central Nervous System Drugs Historic Market, 2012 - 2016; 10.4.3. India Central Nervous System Drugs Forecast Market, 2016 - 2020; 10.4.4. India Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 10.4.5. India Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020; 10.5. Japan Central Nervous System Drugs Market; 10.5.1. Japan Central Nervous System Drugs Market Overview; 10.5.2. Japan Central Nervous System Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Central Nervous System Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 10.5.5. Japan Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020; 10.6. Australia Central Nervous System Drugs Market; 10.6.1. Australia Central Nervous System Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Central Nervous System Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 10.6.4. Australia Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020;

11. Western Europe Central Nervous System Drugs Market;
11.1.1. Western Europe Central Nervous System Drugs Market Overview; 11.1.2. Western Europe Central Nervous System Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Central Nervous System Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 11.2. Western Europe Central Nervous System Drugs Market: Country Analysis; 11.3. UK Central Nervous System Drugs Market; 11.3.1. UK Central Nervous System Drugs Market Overview; 11.3.2. UK Central Nervous System Drugs Historic Market, 2012 - 2016; 11.3.3. UK Central Nervous System Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 11.3.5. UK Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020; 11.4. Germany Central Nervous System Drugs Market; 11.4.1. Germany Central Nervous System Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Central Nervous System Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 11.4.4 Germany Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020; 11.5 France Central Nervous System Drugs Market; 11.5.1 France Central Nervous System Drugs Historic Market, 2012 - 2016; 11.5.2 France Central Nervous System Drugs Forecast Market, 2016 - 2020; 11.5.3 France Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 11.5.4 France Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020; 11.6. Italy Central Nervous System Drugs Market; 11.6.1. Italy Central Nervous System Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Central Nervous System Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 11.6.4. Italy Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020; 11.7. Spain Central Nervous System Drugs Market; 11.7.1. Spain Central Nervous System Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Central Nervous System Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 11.7.4. Spain Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020; 12. Eastern Europe Central Nervous System Drugs Market;

12. Eastern Europe Central Nervous System Drugs Market;
12.1.1. Eastern Europe Central Nervous System Drugs Market Overview; 12.1.2. Eastern Europe Central Nervous System Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Central Nervous System Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 12.2. Eastern Europe Central Nervous System Drugs Market: Country Analysis; 12.3. Russia Central Nervous System Drugs Market; 12.3.1. Russia Central Nervous System Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Central Nervous System Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 12.3.4. Russia Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020;

13. North America Central Nervous System Drugs Market;
13.1.1. North America Central Nervous System Drugs Market Overview; 13.1.2. North America Central Nervous System Drugs Historic Market, 2012 - 2016; 13.1.3. North America Central Nervous System Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 13.2. North America Central Nervous System Drugs Market: Country Analysis; 13.3. USA Central Nervous System Drugs Market; 13.3.1. USA Central Nervous System Drugs Historic Market, 2012 - 2016; 13.3.2. USA Central Nervous System Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 13.3.4. USA Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020;

14. South America Central Nervous System Drugs Market;
14.1.1. South America Central Nervous System Drugs Market Overview; 14.1.2. South America Central Nervous System Drugs Historic Market, 2012 - 2016; 14.1.3. South America Central Nervous System Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 14.2. South America Central Nervous System Drugs Market: Country Analysis; 14.3. Brazil Central Nervous System Drugs Market; 14.3.1. Brazil Central Nervous System Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Central Nervous System Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs; 14.3.4. Brazil Central Nervous System Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Central Nervous System Drugs Expenditure, 2012 - 2020;

15. Middle East Central Nervous System Drugs Market;
15.1.1. Middle East Central Nervous System Drugs Market Overview; 15.1.2. Middle East Central Nervous System Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Central Nervous System Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics; Other CNS Drugs;

16. Africa Central Nervous System Drugs Market;
16.1.1. Africa Central Nervous System Drugs Market Overview; 16.1.2. Africa Central Nervous System Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Central Nervous System Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Central Nervous System Drugs Market, 2016, By Segment; Analgesics; Anti-Parkinson Drugs; Anaesthetics; Anti-Epileptics;

17. Central Nervous System Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Pfizer Inc.; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Biogen Idec; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Novartis Ag; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Otsuka; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Teva Pharmaceuticals; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Central Nervous System Drugs Market;

19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

20. Pharmaceuticals Industry Financial Margins;

21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer